Latest in Finance

Simris Biologics secures €200K funding to develop microcystin-based payloads for antibody-drug conjugates

The Berlin-based subsidiary will use the grant to advance the KlicMic R&D programme, creating targeted microcystin payloads for ADCs that aim to improve cancer therapy efficacy whilst reducing side effects

Find out more

Cytiva and WhiteLab Genomics team up to use AI to accelerate cell line development

Collaboration will accelerate stable cell line development in AAV genomic medicine development and ultimately also shorten the development timeline to clinic
See more

Merck scraps £1bn UK expansion amid concerns as warnings mount over UK’s life sciences competitiveness

The company cited underinvestment in life sciences and the undervaluation of innovative medicines for the decision, raising questions about the UK’s competitiveness in pharmaceutical research and production

Almac expands bioavailability capabilities to address a critical need in drug development

Almac Group has completed a multimillion-pound expansion of its bioavailability enhancement capabilities at its facility in Charnwood, UK

Fidia Farmaceutici enters the UK market with the acquisition of Altacor

Marking another significant milestone in its ongoing international expansion, the company enters the rapidly growing UK ophthalmology market, a key therapeutic area for the group

SGD Pharma acquires Alphial Srl in a strategic step forward

SGD Pharma is pleased to announce an agreement with Italian Private Equity firm Entangled Capital to acquire Alphial Srl, a leading producer of tubular vials and ampoules headquartered in Italy

Piramal and NewAmsterdam Pharma invest in a dedicated suite to enhance oral solid dosage production

The multimillion-dollar investment provides NewAmsterdam Pharma with the commercial capacity to produce a fixed-dose combination (FDC) of obicetrapib and ezetimibe to meet commercial demand

RedHill Biopharma awarded $1.8m in legal costs and expenses by New York Supreme Court

The New York Supreme Court has awarded RedHill $1.82m in legal costs and expenses, in addition to the prior summary judgment of $8.25m, in its action against Kukbo Co. Ltd

Upperton Pharma Solutions advances oral vaccine delivery with Oxford’s Pandemic Sciences Institute

Upperton Pharma Solutions has been awarded a grant as part of the first VaxHub Sustainable Platform Funding Call, in collaboration with the University of Oxford

Continuous innovation: redefining the future of pharmaceutical manufacturing

In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced

Latest posts in Finance

CPTx and NanoCell awarded EU funding for in vivo CAR T therapy with immune-silent single-stranded DNA

The QUIET-CAR project that targets cancer and autoimmune diseases is top-ranked among the 120-plus Eurostars Grant submissions

Panthera Biopartners secures investment from LDC to accelerate expansion

Panthera Biopartners has secured investment from leading private equity investor LDC to support its expansion plans and further enhance its clinical capabilities

Sartorius Stedim Biotech and Nanotein partner to advance cell therapy manufacturing

Nanotein’s NanoSpark reagents enhance cell activation and expansion in cell therapy manufacturing

Biocair announces rapid APAC expansion with new office in Shanghai

The office is collocated with its warehouse to facilitate operations and enable enhanced collaboration between the operations, sales, warehouse and transportation teams

Vertex announces the results of a Phase II study of VX-993 to treat acute pain

Treatment with the selective NaV1.8 pain signal inhibitor VX-993 after bunionectomy surgery did not meet the primary endpoint

Bora Pharmaceuticals announces multi-year expansion for midwest manufacturing site

Build-out includes Gerteis Macro-Pactor install, with additional investments to follow, to meet industry demand at the Minnesota facility

Stevanato Group reports revenue of €280.0m for the second quarter of 2025

Company delivers 8% revenue growth, expanded margins and maintains fiscal year 2025 guidance

Gerresheimer to divest Moulded Glass business following strategic review

As part of its transformation into a pure-play pharma and biotech systems provider, Gerresheimer has announced plans to sell its newly formed global Moulded Glass Powerhouse. The decision follows a strategic review that identified stronger growth opportunities for the business outside the Group

Applied Biopharm Consulting announces new address at West Cork Business and Technology Park

This strategic move reflects Applied Biopharm’s commitment to serving the expanding global demand for high-quality consulting services in the biologics and gene therapy space

Antibodies.com expands UK headquarters to accommodate rapid growth

Relocation increases logistics and R&D capacity, enabling faster customisation and turnaround, strengthening order fulfilment to better support customers with their research and development efforts

University of Minnesota researchers awarded $665,000 in G-Rex Grants from ScaleReady

ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, has awarded $665,000 in G-Rex Grants to three researchers at the University of Minnesota’s Centre for Genome Engineering

Sponsor content

GEA raises guidance following strong H1 performance

Revised forecast reflects improved margins, robust order intake and efficiency gains

Lonza delivers strong H1 2025 performance

Lonza delivers strong H1 2025 performance and upgrades 2025 full-year CDMO sales and margin outlook

Gerresheimer reports H1 2025 growth driven by Bormioli Pharma acquisition

Cosmetics and oral liquids markets dampen organic revenue but outlook remains strong

Almac completes a multi-million-pound investment enhancing cold chain capabilities in Craigavon

Almac Clinical Services, part of the Almac Group, has completed a multi-million-pound investment to enhance cold chain capabilities at its global headquarters in...

CARBOGEN AMCIS accelerates manufacturing capacity with CHF 25.5 million co-investment at Swiss sites

CARBOGEN AMCIS is pleased to announce a strategic co-investment of more than CHF 25 million with a long-standing Japanese customer to expand manufacturing capabilities at...

Gerresheimer adjusts guidance for Financial Year 2025

Gerresheimer is adjusting its guidance for 2025 due to continuing subdued demand in the cosmetics market and a decline in demand for plastic containment solutions for oral...

Almac Group hits record £1 billion revenue milestone

Strong financials support expansion in manufacturing and clinical capabilities

Lonza publishes updated 2024 financials ahead of One Lonza reporting

New CDMO platform structure supports upcoming half-year 2025 results

Vetter once again named best managed company

The award jury recognises strategic and sustainable corporate management

SCHOTT Pharma delivers strong second quarter of fiscal year 2025

SCHOTT Pharma, a pioneer in pharma drug containment solutions and delivery systems, today published its results for the second quarter of the fiscal year 2025

Gerresheimer: Bormioli Pharma boosts revenues and earnings

Gerresheimer recorded a jump in revenues and earnings due to the first-time consolidation of Bormioli Pharma, which was acquired in 2024

Piramal Pharma Limited announces results for Q3 and 9M FY25

Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635) announced its standalone and consolidated results for the Third Quarter (Q3) and Nine Months (9M) ended 31st December...